Angiogenesis inhibitor
    2.
    发明授权
    Angiogenesis inhibitor 失效
    血管生成抑制剂

    公开(公告)号:US06551999B1

    公开(公告)日:2003-04-22

    申请号:US09243822

    申请日:1999-02-03

    IPC分类号: C07K506

    摘要: An angiogenesis inhibitor comprising a cysteine protease inhibitory compound. As the preferable cysteine protease inhibitory compound, epoxysuccinic acid compounds, peptide halohydrazide compounds, calpain inhibitory compounds, compounds of the formula (I) and compounds of the formula (VI) can be used. The angiogenesis inhibitor of the present invention suppresses new formation of blood vessels in the living tissues, so that it can be used as a superior therapeutic or prophylactic agent of angiogenesis associated with wound healing, inflammation, growth of tumor and the like; and angiogenesis as seen in diabetic retinopathy, prematurity retinopathy, retinal venous occlusion, senile discoid macular degeneration and the like, as well as for prevention of metastasis of tumors.

    摘要翻译: 一种包含半胱氨酸蛋白酶抑制化合物的血管生成抑制剂。 作为优选的半胱氨酸蛋白酶抑制化合物,可以使用环氧琥珀酸化合物,肽卤代酰肼化合物,钙蛋白酶抑制化合物,式(I)的化合物和式(VI)的化合物。 本发明的血管发生抑制剂抑制活组织中血管的新形成,可以用作与伤口愈合,炎症,肿瘤生长等有关的血管生成的优异治疗或预防剂。 和血管生成,如糖尿病视网膜病变,早产儿视网膜病变,视网膜静脉闭塞,老年性盘状黄斑变性等,以及用于预防肿瘤转移。

    Angiogenesis inhibitor
    6.
    发明授权
    Angiogenesis inhibitor 失效
    血管生成抑制剂

    公开(公告)号:US6057290A

    公开(公告)日:2000-05-02

    申请号:US740069

    申请日:1996-10-24

    摘要: An angiogenesis inhibitor comprising a cysteine protease inhibitory compound. As the preferable cysteine protease inhibitory compound, epoxysuccinic acid compounds, peptide halohydrazide compounds, calpain inhibitory compounds, compounds of the formula (I) ##STR1## and compounds of the formula (VI) ##STR2## can be used. The angiogenesis inhibitor of the present invention suppresses new formation of blood vessels in the living tissues, so that it can be used as a superior therapeutic or prophylactic agent of angiogenesis associated with wound healing, inflammation, growth of tumor and the like; and angiogenesis as seen in diabetic retinopathy, prematurity retinopathy, retinal venous occlusion, senile discoid macular degeneration and the like, as well as for prevention of metastasis of tumors.

    摘要翻译: 一种包含半胱氨酸蛋白酶抑制化合物的血管生成抑制剂。 作为优选的半胱氨酸蛋白酶抑制化合物,可以使用环氧琥珀酸化合物,肽卤代酰肼化合物,钙蛋白酶抑制化合物,式(I)的化合物和式(VI)的化合物。 本发明的血管发生抑制剂抑制活组织中血管的新形成,可以用作与伤口愈合,炎症,肿瘤生长等有关的血管生成的优异治疗或预防剂。 和血管生成,如糖尿病视网膜病变,早产儿视网膜病变,视网膜静脉闭塞,老年性盘状黄斑变性等,以及用于预防肿瘤转移。

    Angiogenesis inhibitor
    8.
    发明授权
    Angiogenesis inhibitor 失效
    血管生成抑制剂

    公开(公告)号:US06214800B1

    公开(公告)日:2001-04-10

    申请号:US09282501

    申请日:1999-04-09

    IPC分类号: A61K3800

    摘要: An angiogenesis inhibitor comprising a cysteine protease inhibitory compound. As the preferable cysteine protease inhibitory compound, epoxysuccinic acid compounds, peptide halohydrazide compounds, calpain inhibitory compounds, compounds of the formula (I) and compounds of the formula (VI) can be used. The angiogenesis inhibitor of the present invention suppresses new formation of blood vessels in the living tissues, so that it can be used as a superior therapeutic or prophylactic agent of angiogenesis associated with wound healing, inflammation, growth of tumor and the like; and angiogenesis as seen in diabetic retinopathy, prematurity retinopathy, retinal venous occlusion, senile discoid macular degeneration and the like, as well as for prevention of metastasis of tumors.

    摘要翻译: 一种包含半胱氨酸蛋白酶抑制化合物的血管生成抑制剂。 作为优选的半胱氨酸蛋白酶抑制化合物,可以使用环氧琥珀酸化合物,肽卤代酰肼化合物,钙蛋白酶抑制化合物,式(I)的化合物和式(VI)的化合物。 本发明的血管发生抑制剂抑制活组织中血管的新形成,可以用作与伤口愈合,炎症,肿瘤生长等有关的血管生成的优异治疗或预防剂。 和血管生成,如糖尿病视网膜病变,早产儿视网膜病变,视网膜静脉闭塞,老年性盘状黄斑变性等,以及用于预防肿瘤转移。